Home › FDA OKs Cubist antibiotic for serious infections
 

Keywords :   


FDA OKs Cubist antibiotic for serious infections

2014-12-20 02:18:07| Biotech - Topix.net

The Food and Drug Administration has approved a new combination medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved this year. The approval of Zerbaxa is the second antibiotic approval this year for Cubist Pharmaceuticals, which agreed earlier this month to be acquired for $8.4 billion by the world's fourth-biggest drug maker, Merck & Co.

Tags: infections fda antibiotic oks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
09.11Atlantic Tropical Weather Outlook
09.11Eastern North Pacific Tropical Weather Outlook
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 22
08.11Hurricane Rafael Forecast Advisory Number 22
08.11Hurricane Rafael Public Advisory Number 22
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11Trump tariffs could cost UK 22bn of exports
More »